The IGF-1R pathway as a therapeutic target

Oncology

Volumn 25, Issue 6, 2011, Pages

  Chu, Edward ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANITUMAB; GEMCITABINE; INSULIN GROWTH FACTOR RECEPTOR 1; INSULIN GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; SOMATOMEDIN RECEPTOR; UNCLASSIFIED DRUG;

ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER RESISTANCE; CANCER SURVIVAL; CIRCULATING TUMOR CELL; COLORECTAL CANCER; DRUG EFFICACY; DRUG POTENCY; EWING SARCOMA; FATIGUE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOPHYSIS; LIVER CANCER; LUNG CANCER; LUNG NON SMALL CELL CANCER; MELANOMA; NEUROENDOCRINE TUMOR; OSTEOSARCOMA; OVERALL SURVIVAL; PANCREAS CANCER; PERIPHERAL BLOOD MONONUCLEAR CELL; PHARMACODYNAMICS; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TARGETING; RHABDOMYOSARCOMA; RISK ASSESSMENT; SIGNAL TRANSDUCTION; THROMBOCYTOPENIA;

EID: 79957521211     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Zhang H, Yee D. The therapeutic potential of agents targeting the type I insulin-like growth factor receptor. Expert Opin Investig Drugs. 2004;13:1569-77.
2. Hartog H, Wesseling J, Boezen HM, et al. The insulin-like growth factor I receptor I cancer: old focus, new future. Eur J Cancer. 2007;43:1895-1904.
3. Pollak M. Insulin and insulin-like growth factor signaling in neoplasia. Nat Rev Cancer. 2008;8:915-28.
4. Rodon J, DeSantos V, Ferry RJ, Kurzock R. Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons learned from the first clinical trials. Mol Cancer Ther. 2008;7:2575-88.
5. Lopez-Calderero I, Chavez ES, Garcia-Carbonero R. The insulin-like growth factor pathway as a target for cancer therapy. Clin Transl Oncol. 2010;12:326-38.
6. Zha J, Lackner MR. Targeting the insulin-like growth factor receptor-1R pathway for cancer therapy. Clin Cancer Res. 2010;16:2512-7.
7. Carden DP, Molife LR, deBono JS. Predictive biomarkers for targeting insulin-like growth factor-I (IGF-1) receptor. Mol Cancer Ther. 2009;8:2077-8.